HemaQuest Pharmaceuticals Receives $4,000,000 Series B Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37c0f677-bbd5-4a15-be27-f940911161d4&Preview=1
Date
7/28/2010
Company Name
HemaQuest Pharmaceuticals
Mailing Address
1229 Madison Street Seattle, WA 98104
Company Description
HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders.
Website
http://www.hemaquest.com
Transaction Type
Venture Equity
Transaction Amount
$4,000,000
Transaction Round
Series B
Proceeds Purposes
The financing will be used to help push HemaQuest’s two lead drug candidates through mid-stage clinical trials designed to show they are safe and effective.
M&A Terms
Venture Investor
Latterell Venture Partners